Renovaro Biosciences
RENB
#7735
Rank
โ‚ฌ0.24 B
Marketcap
1,57ย โ‚ฌ
Share price
6.15%
Change (1 day)
-46.70%
Change (1 year)

EPS for Renovaro Biosciences (RENB)

EPS in 2023 (TTM): -1,94ย โ‚ฌ

According to Renovaro Biosciences's latest financial reports the company's current EPS (TTM) is -1,94ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of -1,97ย โ‚ฌ a decrease over its 2021 EPS that were of -0,76ย โ‚ฌ.

EPS history for Renovaro Biosciences from 2012 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-1,94ย โ‚ฌ-1.87%
2022-1,97ย โ‚ฌ160.76%
2021-0,76ย โ‚ฌ243.48%
2020-0,22ย โ‚ฌ43.75%
2019-0,15ย โ‚ฌ-74.87%
2018-0,61ย โ‚ฌ339.47%
2017-0,14ย โ‚ฌ-48.26%
2016-0,27ย โ‚ฌ-22.22%
2015-0,34ย โ‚ฌ7.39%
2014-0,32ย โ‚ฌ4351.27%
2013-0,007215ย โ‚ฌ16.6%
2012-0,006188ย โ‚ฌ